SELLAS Life Sciences (SLS) Short term Debt (2013 - 2018)

SELLAS Life Sciences (SLS) has 6 years of Short term Debt data on file, last reported at $76000.0 in Q3 2018.

• On a quarterly basis, Short term Debt fell 99.38% year-over-year to $76000.0 in Q3 2018; TTM through Sep 2018 was $76000.0, a 99.38% decrease from a year earlier, with the FY2017 full-year figure at $8.4 million, up 390.17% from the prior year.
• Short term Debt for Q3 2018 stood at $76000.0, down from $7.8 million in the prior quarter.
• Over the last five years, Short term Debt for SLS reached as high as $23.7 million in Q3 2016 and fell as low as $76000.0 in Q3 2018.
• Historically, Short term Debt has averaged $7.7 million across 5 years, with a median of $4.2 million in 2015.
• Across the five-year window, Short term Debt surged 1254.15% in 2014 and tumbled 99.38% in 2018, its largest moves.
• Year by year, Short term Debt stood at $3.9 million in 2014, then gained by 21.2% to $4.7 million in 2015, then plunged by 63.94% to $1.7 million in 2016, then jumped by 390.17% to $8.4 million in 2017, then tumbled by 99.09% to $76000.0 in 2018.
• Per Business Quant data, the three most recent Short term Debt figures were $76000.0 in Q3 2018, $7.8 million in Q2 2018, and $8.5 million in Q1 2018.